Xu, J., McCoy, M., Martinez, Z., Sussman, J. H., Gao, D., Vincent, T. L., Wang, H., Ma, C., Elghawy, O., Chen, G. M., Yang, A. G., Polonen, P., Natan, K., Shraim, R., Newman, H., Hofmann, T. J., Scoma, S., DiNofia, A. M., Hunger, S. P., Yang, J. J., Mullighan, C. G., Bernt, K. M., Hexner, E. O., Grupp, S. A., Watanabe, K., June, C. H., Tan, K., Teachey, D. T., Diorio, C. CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia , Blood Adv: 2026
Louloudis, I. E., Chen, Y. B., Spyrou, N., Alousi, A., Katsivelos, N., Ayuk, F., Weber, D., Hogan, W. J., Etra, A. M., Qayed, M., Aguayo-Hiraldo, P., Akahoshi, Y., Malki, M. M. A., Bolanos-Meade, J., Chanswangphuwana, C., Diniz, M., Eder, M., Hexner, E., Kitko, C. L., Kraus, S., Merli, P., Olson, T., MacMillan, M. L., Pidala, J., Reshef, R., Schechter, T., Wolfl, M., Baez, J., Eng, G., Gleich, S., Young, R., Nakamura, R., Ferrara, J. L. M., Levine, J. E. Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity , Transplant Cell Ther, 32(1): 2026,63 e1-63 e11
Gotlib, J., Reiter, A., Radia, D. H., Alvarez-Twose, I., Deininger, M. W., George, T. I., Panse, J. P., Mital, A., Pettit, K. M., Vannucchi, A. M., Platzbecker, U., Hermine, O., Elshoury, A., Livideanu, C., Mesa, R. A., Ustun, C., Triggiani, M., Dybedal, I., Jurcic, J. G., Zanotti, R., Oh, S. T., Yacoub, A., Hexner, E. O., Bose, P., Lee, S. G., Sperr, W. R., Griffiths, E. A., Butler, M., Lubke, J., Bidollari, I., Lin, H. M., Rylova, S. N., Dimitrijevic, S., Munoz-Gonzalez, J. I., DeAngelo, D. J. Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study , Blood Adv: 2026
Deng, M. Z., Sinha, T., Lai, M., Jiang, S., Kong, H., Cooper, V., Gu, M., Perelman, J., Zhang, C., Hanindya, C., Carpio, V., Keller, P., Jadlowsky, J. K., Leskowitz, R., McKenna, S., Four, M., Barranco, J. A. J., Cooper, N., Jain, A., Haines, K., Gohil, M., Garcia-Gerique, L., Russell, A., Kulikovskaya, I., Gonzalez, V., Fraietta, J. A., Plesa, G., Sheppard, N. C., Davis, M. M., Chew, A., Hexner, E., Frey, N., June, C. H., Svoboda, J., Riley, J. L. Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells , Res Sq: 2026
Chen, G. M., Jain, A., Gering, D. T., Satulovsky, J., Datta, S., Lai, P., Karar, J., Gonzalez, V. E., Alexander, K., Chew, A., Jadlowsky, J. K., Ruella, M., Paruzzo, L., Amses, K. R., Rech, A. J., Stadtmauer, E. A., Frey, N. V., Hexner, E. O., Porter, D. L., Cohen, A. D., Gill, S. I., Garfall, A. L., Schuster, S. J., Mo, K. C., Liang, S. I., Spasic, M., Levine, B. L., Siegel, D. L., Ramirez-Fernandez, A., Cabanski, C. R., Yang, E., Mackall, C. L., Bushman, F. D., Good, Z., John Wherry, E., June, C. H., Fraietta, J. A. Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer , Nat Biomed Eng: 2026
Barber-Rotenberg, J. S., Haas, A. R., Aggarwal, C., O'Hara, M., Hexner, E., Pequignot, E., Dowd, E., Ndeupen, S., Thai, E., Chen, F., Oner, B. S., Czuczman, C., Gonzalez, V. E., Fraietta, J. A., Hwang, W. T., Chew, A., Jadlowsky, J. K., Marshall, A., Shea, K. M., Jiang, Y., Cosey, A., Ferthio, R., Levine, B. L., Plesa, G., Siegel, D. L., Young, R. M., Sheppard, N. C., Albelda, S. M., June, C. H., Tanyi, J. L. Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers , Mol Ther: 2026
Salit RB, Hexner EO, Gagelmann N, Kröger N, McLornan DP, Jain T, Gupta V, Hobbs GS, Tamari R, Robin M, Scott B, Saber W Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus , Leukemia: 2025
Aznar MA, Good CR, Barber-Rotenberg JS, Agarwal S, Wilson W, Watts A, Zhang Z, Gonzales D, Donahue G, Hwang WT, Rennels AK, Rech AJ, Kuramitsu S, Huang H, Glastad KM, Alexander KA, Plesa G, Dowd E, Brennan A, Siegel DL, Tanyi J, Haas A, Torigian DA, Nadolski G, Gonzalez VE, Hexner EO, Fraietta JA, Jadlowsky JK, Young RM, Berger SL, June CH, O'Hara MH Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer , Cell Rep Med, 6(9): 2025,102301.
Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, Gopikrishna GK, Rech AJ, Nabavizadeh A, Bagley LJ, Park J, Jarocha D, Martins R, Sarmiento N, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz RM, Jadlowsky JK, Mackey S, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Barrett D, Colbourn R, Nasrallah MP, Mourelatos Z, Hwang WT, Alanio C, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM. Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial , Nat Med, 31(9): 2025,3205
Akahoshi Y, Inamoto Y, Spyrou N, Nakasone H, Diniz M, Asada N, Ayuk FA, Choe HK, Doki N, Eto T, Etra AM, Hexner EO, Hiramoto N, Hogan WJ, Holler EPDm, Kataoka K, Kawakita T, Tanaka M, Tanaka T, Uchida N, Vasova I, Yoshihara S, Ishimaru F, Fukuda T, Chen YB, Kanda J, Nakamura R, Atsuta Y, Ferrara JLM, Kanda Y, Levine JE, Teshima T. Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC , Blood Adv. , 9(18): 2025,4640-4653.
